Cocaine vaccine dAd5GNE protects against moderate daily and high-dose “binge” cocaine use is a research paper published in PLoS ONE (2020). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Drug Abuse
Grant: DA028847
National Institute on Drug Abuse
Grant: R01DA032702
National Institute on Drug Abuse
Grant: U01DA048524
National Institute on Drug Abuse
Grant: N01DA-9-7767
NIDA NIH HHS
Grant: RC2 DA028847
NIH HHS
Grant: P40 OD010965
NCATS NIH HHS
Grant: UL1 TR002384
National Institutes of Health
Grant: 1R01DA007767-01A2
VULNERABILITY TO COCAINE TOXICITY--GENETIC MECHANISMS
National Institutes of Health
Grant: 5R01DA032702-03
Second-generation Gene Transfer Vector-based Anti-cocaine Vaccines
National Institutes of Health
Grant: 1U01DA048524-01
Clinical Assessment of Anti-cocaine Vaccine dAdGNE in Cocaine Addicts
National Institutes of Health
Grant: 5RC2DA028847-02
Adenovirus-based Anti-Cocaine Vaccine
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals